Stock XGN EXAGEN INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Exagen Inc.

Equities

XGN

US30068X1037

Market Closed - Nasdaq
Other stock markets
 21:30:00 30/04/2024 BST 		5-day change 1st Jan Change
1.385 USD -1.74% Intraday chart for Exagen Inc. -1.04% -30.38%
04-26 Exagen Inc. Announces Changes in Board of Directors CI
03-18 Exagen Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Exagen to Announce First Quarter 2024 Results on May 13, 2024
GL
Exagen to Announce First Quarter 2024 Results on May 13, 2024
AQ
Exagen Inc. Announces Changes to the Board of Directors
AQ
Exagen Inc. Announces Changes to the Board of Directors
GL
Exagen Inc. Announces Changes in Board of Directors
CI
Exagen Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Earnings Flash (XGN) EXAGEN Reports Q4 Revenue $13.8M, vs. Street Est of $11.6M
MT
Transcript : Exagen Inc., Q4 2023 Earnings Call, Mar 18, 2024
Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 Results
GL
Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 Results
AQ
Exagen Inc. Provides Earnings Guidance for the First Quarter and Full Year 2024
CI
Exagen Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
North American Morning Briefing : Investors -2-
DJ
Exagen Inc. to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
GL
Exagen Inc. to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
AQ
Exagen to Announce Fourth Quarter 2023 and Full-Year Financial Results on March 18, 2024
GL
Exagen Inc. to Participate in the 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
GL
Exagen Inc. Announces Select Preliminary Full-Year 2023 Results and Reaffirms Guidance
AQ
Exagen Inc. Reaffirms Earnings Guidance for the Full Year Ended December 31, 2023
CI
Exagen Inc. Announces Select Preliminary Full-Year 2023 Results and Reaffirms Guidance
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. XGN Stock
  4. News Exagen Inc.